SCHEMBL19079843

SCHEMBL19079843

CCn1c(SCC(=O)c2cccs2)nc2sc3c(c2c1=O)CCCC3

nearest known ligand 0.87

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4D Q08499 3/20 0.87
▸ ALDH1A1 P00352 3/20 0.68
▸ SMN1; SMN2 Q16637 3/20 0.68
▸ POLB P06746 7/20 0.67
▸ TDP1 Q9NUW8 5/20 0.67
▸ RECQL P46063 3/20 0.67
▸ NR4A1 P22736 2/20 0.67
▸ PTPN7 P35236 2/20 0.67
▸ APEX1 P27695 1/20 0.67
▸ APOBEC3A P31941 1/20 0.67
▸ APOBEC3G Q9HC16 1/20 0.67
▸ THRB P10828 1/20 0.65
▸ L3MBTL1 Q9Y468 4/20 0.64
▸ MAPT P10636 3/20 0.64
▸ HSD17B10 Q99714 2/20 0.64
▸ MEN1 O00255 2/20 0.64
▸ KMT2A Q03164 2/20 0.64
▸ CYP1A2 P05177 1/20 0.64
▸ CYP2C9 P11712 1/20 0.64
▸ MAPK1 P28482 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079690 0.93 PDE4D (1.00) PDE4DALDH1A1SMN1; SMN2POLBTDP1
SCHEMBL19079837 0.91 PDE4D (0.81) PDE4DALDH1A1SMN1; SMN2POLBTDP1
SCHEMBL19079833 0.90 PDE4D (0.80) PDE4DALDH1A1SMN1; SMN2POLBTDP1
SCHEMBL17597465 0.90 PDE4D (1.00) PDE4DALDH1A1SMN1; SMN2POLBTDP1
SCHEMBL19079834 0.90 PDE4D (0.79) PDE4DALDH1A1SMN1; SMN2POLBTDP1
SCHEMBL19079720 0.89 PDE4D (0.77) PDE4DALDH1A1SMN1; SMN2POLBTDP1
SCHEMBL3914072 0.89 PDE4D (0.77) PDE4DALDH1A1SMN1; SMN2POLBMAPT
SCHEMBL19079838 0.89 PDE4D (0.77) PDE4DALDH1A1SMN1; SMN2POLBTDP1
SCHEMBL19079728 0.88 PDE4D (0.76) PDE4DALDH1A1SMN1; SMN2POLBTDP1
SCHEMBL19079832 0.86 PDE4D (0.74) PDE4DALDH1A1SMN1; SMN2POLBTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase VANDERBILT UNIVERSITY (US) 2019-06-25 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase PDE4A, PDE4B, PDE7A PDE4D 6/4885ALDH1A1 1503/4885SMN1; SMN2 4025/4885
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase PDE4A, PDE4B, PDE7A PDE4D 6/4885ALDH1A1 1503/4885SMN1; SMN2 4025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback